Investigational Drug 1 (MK-0217-907)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Investigational Drug 1 (MK-0217-907), covering 2024-08-14 to 2024-08-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) [Phase 3]